Literature DB >> 21684608

Retinal video recording a new way to image and diagnose diabetic retinopathy.

Daniel S W Ting1, Mei Ling Tay-Kearney, Ian Constable, Liam Lim, David B Preen, Yogesan Kanagasingam.   

Abstract

PURPOSE: To validate the use of retinal video recording for diabetic retinopathy screening by comparing with standard retinal photography and slit-lamp examination.
DESIGN: Evaluation of a new diagnostic technique. PARTICIPANTS: One hundred patients.
METHODS: All fundus images were captured using standard retinal still photography (FF 450 plus; Carl Zeiss) and retinal video (EyeScan; Ophthalmic Imaging System, Sacramento, CA), followed by a gold standard slit-lamp biomicroscopy examination. All videos and still images were de-identified, randomized, and interpreted by 2 senior consultant ophthalmologists (M.L.T-K. and L.L.). Kappa statistics, sensitivity, and specificity for all the diabetic retinopathy signs and grades were calculated with reference to slit-lamp examination results as the gold standard. MAIN OUTCOME MEASURES: Sensitivity and specificity of video recording for detecting diabetic retinopathy signs and grades.
RESULTS: The mean age (± standard deviation [SD]) of participants was 52.8 ± 15.1 years, mean duration of diabetes (± SD) was 13.7 ± 9.7 years, and the mean glycosylated hemoglobin level was 8.0 ± 1.7%. Compared with the gold standard slit-lamp examination results, the sensitivity and specificity of video recording for detecting the presence of any diabetic retinopathy was 93.8% and 99.2%, respectively (ophthalmologist 1), and 93.3% and 95.2%, respectively (ophthalmologist 2). In contrast, the sensitivity and specificity of retinal photography was 91.8% and 98.4%, respectively (ophthalmologist 1), and 92.1% and 96.8%, respectively (ophthalmologist 2), for detection of any diabetic retinopathy. Both imaging methods had 100% sensitivity and specificity in detecting sight-threatening diabetic retinopathy. For overall diabetic retinopathy grading by both ophthalmologists, the measurements of agreement (Cohen's κ coefficient) between the overall grading obtained from the retinal video versus slit-lamp examination and retinal photography versus slit-lamp examination were more than 0.90. Technical failure rate for retinal video recording and retinal photography were 7.0% and 5.5%, respectively.
CONCLUSIONS: This study demonstrated that retinal video recording was equally as effective as retinal photography in the subjects evaluated in this study. It is a novel alternative diabetic retinopathy screening technique that not only offers primary eye care providers the opportunity to view numerous retinal fields within a short period but also is easy to learn by nonexperienced personnel with minimal training. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684608     DOI: 10.1016/j.ophtha.2011.04.009

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Diabetic retinopathy screening: can the viewing monitor influence the reading and grading outcomes.

Authors:  D S W Ting; M L Tay-Kearney; J Vignarajan; Y Kanagasingam
Journal:  Eye (Lond)       Date:  2012-10-12       Impact factor: 3.775

2.  Retinal video recordings at different compression levels: a novel video-based imaging technology for diabetic retinopathy screening.

Authors:  D S W Ting; M L Tay-Kearney; I Constable; J Vignarajan; Y Kanagasingam
Journal:  Eye (Lond)       Date:  2013-05-10       Impact factor: 3.775

Review 3.  Artificial intelligence and deep learning in ophthalmology.

Authors:  Daniel Shu Wei Ting; Louis R Pasquale; Lily Peng; John Peter Campbell; Aaron Y Lee; Rajiv Raman; Gavin Siew Wei Tan; Leopold Schmetterer; Pearse A Keane; Tien Yin Wong
Journal:  Br J Ophthalmol       Date:  2018-10-25       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.